James P. Kelly
2018 - Vanda Pharmaceuticals
In 2018, James P. Kelly earned a total compensation of $2.2M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $299,375 |
|---|---|
| Option Awards | $805,077 |
| Salary | $479,000 |
| Stock Awards | $618,600 |
| Other | $36,778 |
| Total | $2,238,830 |
Kelly received $805.1K in option awards, accounting for 36% of the total pay in 2018.
Kelly also received $299.4K in non-equity incentive plan, $479K in salary, $618.6K in stock awards and $36.8K in other compensation.
Rankings
In 2018, James P. Kelly's compensation ranked 5,148th out of 14,244 executives tracked by ExecPay. In other words, Kelly earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,148 out of 14,244 | 64th |
Division Manufacturing | 1,941 out of 5,759 | 66th |
Major group Chemicals And Allied Products | 711 out of 2,122 | 67th |
Industry group Drugs | 594 out of 1,811 | 67th |
Industry Pharmaceutical Preparations | 457 out of 1,385 | 67th |
Source: SEC filing on April 25, 2019.
Kelly's colleagues
We found four more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2018.
2018
Mihael Polymeropoulos
Vanda Pharmaceuticals
Chief Executive Officer
2018
Timothy Williams
Vanda Pharmaceuticals
General Counsel
2018
Gian Reverberi
Vanda Pharmaceuticals
Senior Vice President, Chief Commercial Officer
2018
Gunther Birznieks
Vanda Pharmaceuticals